Tuesday, August 11, 2026
LIVEThe Unrelenting Cyber Battle: Hacking Threats and the Imperative of Robust Data Protection///Navigating the Cyber Labyrinth: Bolstering Defenses Against Evolving Hacking Threats///The Dual Front War: Battling Hacking and Bolstering Data Protection in the Digital Age///The Ever-Evolving Cyber Threat Landscape: Navigating Hacking and Fortifying Data Protection///The Unseen Battle: Fortifying Data in an Age of Relentless Hacking///The Unseen War: Hacking's Relentless Advance and the Imperative of Data Protection///The Evolving Threat Landscape: Hacking, Data Protection, and the Imperative for Proactive Security///Navigating the Digital Minefield: Bolstering Data Protection in an Era of Relentless Hacking///The Dual Fronts of Digital Defense: Combating Hacking and Fortifying Data Protection///Hacking's New Frontier: Fortifying Data Protection in the Age of Advanced Cyber Threats///The Dual Front: Navigating Hacking Threats and Fortifying Data Protection in the Digital Age///Navigating the Digital Gauntlet: The Evolving Nexus of Hacking and Data Protection///The Unrelenting Cyber Battle: Hacking Threats and the Imperative of Robust Data Protection///Navigating the Cyber Labyrinth: Bolstering Defenses Against Evolving Hacking Threats///The Dual Front War: Battling Hacking and Bolstering Data Protection in the Digital Age///The Ever-Evolving Cyber Threat Landscape: Navigating Hacking and Fortifying Data Protection///The Unseen Battle: Fortifying Data in an Age of Relentless Hacking///The Unseen War: Hacking's Relentless Advance and the Imperative of Data Protection///The Evolving Threat Landscape: Hacking, Data Protection, and the Imperative for Proactive Security///Navigating the Digital Minefield: Bolstering Data Protection in an Era of Relentless Hacking///The Dual Fronts of Digital Defense: Combating Hacking and Fortifying Data Protection///Hacking's New Frontier: Fortifying Data Protection in the Age of Advanced Cyber Threats///The Dual Front: Navigating Hacking Threats and Fortifying Data Protection in the Digital Age///Navigating the Digital Gauntlet: The Evolving Nexus of Hacking and Data Protection///
Subscribe
Cyber Security
Independent · Digital
Thehackingpost
CybersecurityAI-assisted

Deep Intelligent Pharma (DIP) Raises Nearly 50 Million USD in Series D Financing

## Deep Intelligent Pharma Secures Series D Funding

Deep Intelligent Pharma Secures Series D Funding

Deep Intelligent Pharma (DIP), a leader in AI-driven drug research and development platforms, has announced the completion of nearly $50 million in Series D financing. The funding round was led by CDH Baifu, with participation from existing investors Xinding Capital and HongShan Capital. Index Capital served as the exclusive financial advisor.

The funds will be utilized for the iterative development of DIP's end-to-end autonomous clinical system and the expansion of its global commercialization network. This aims to accelerate the transition from assistive tools to decision-making infrastructure.

Technological Advancements in Drug Development

AI Integration in Pharmaceutical R&D

Traditional drug research and development face challenges such as lengthy development cycles and high costs. DIP's AI-driven platform addresses these by moving beyond traditional models to intelligent decision systems, enhancing the probability of success in drug development.

Development of a Multi-Agent Ecosystem

DIP has developed a multi-agent ecosystem based on bionics, featuring:

Cognitive Atomism

The funding round was led by CDH Baifu, with participation from existing investors Xinding Capital and HongShan Capital.
Grace Bennett · Thehackingpost

DIP's system decomposes complex clinical logic into over 10,000 high-precision atomic agents, each functioning akin to a specialist.

Human-Brain Bionics

The system is trained on extensive past project data, developing a reflection mechanism that enables hypothesis formulation and validation.

High Precision

DIP's AI achieves 99.9% industrial-grade accuracy, overcoming common challenges in medical AI applications.

Advertisement

Commercialization and Real-World Applications

DIP’s comprehensive product matrix covers protocol design, biostatistics, pharmacovigilance, and clinical operations, demonstrating significant performance advantages in real-world deployments.

Investor Confidence and Future Outlook

Leading investors express strong confidence in DIP's potential to transform the pharmaceutical R&D landscape. The company's innovative approach positions it strategically in the global AI-driven healthcare industry.

Founded in 2017, Deep Intelligent Pharma is dedicated to revolutionizing drug development through artificial intelligence. The company combines AI expertise with clinical experience to provide comprehensive solutions across the drug development lifecycle.

Based on reporting by TechBullion.

AI transparency. This article was produced with the assistance of artificial intelligence and published under human editorial oversight. AI systems can make mistakes. Read how we use AI (EU AI Act, Art. 50).
Related Stories